A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression

Overview of attention for article published in Breast Cancer Research and Treatment, June 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 49 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING UVEAL MELANOMA

Application WO-2020239685-A1

World Intellectual Property Organisation (WIPO)